Whalen Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$456K Buy
3,629
+235
+7% +$29.5K 0.29% 103
2025
Q1
$375K Buy
3,394
+1,461
+76% +$162K 0.25% 92
2024
Q4
$264K Buy
+1,933
New +$264K 0.18% 107